Researchers identify promising target to slow Alzheimer's

December 17, 2000

Click here for abstract:


HONOLULU, Dec. 18 - Researchers believe that a chemical called methionine plays a role in Alzheimer's disease and also could explain how vitamin E slows the progress of the disease in its later stages. The finding could lead to new drugs to delay the advance of Alzheimer's, say the researchers, who presented their study today during the 2000 International Chemical Congress of Pacific Basin Societies.

The weeklong scientific meeting, held once every five years, is hosted by the American Chemical Society, in conjunction with its counterparts in Australia, Canada, Japan and New Zealand.

Alzheimer's is a chronic form of dementia that primarily strikes the elderly and causes severe memory loss and, eventually, death. The disease is characterized by the overproduction of a protein, beta-amyloid, that accumulates in the brain of its victims. Although normal brains contain beta-amyloid, those with the disease have comparatively large amounts. The protein is thought to produce chemicals called free radicals, which are toxic to the brain, according to the study's lead researcher, Allan Butterfield, Ph.D., a professor of chemistry and director of the Center for Membrane Sciences at the University of Kentucky in Lexington.

Butterfield examined the sequence of amino acids in beta-amyloid and found that one in particular - methionine - is the likely source of the toxic free radicals. He then modified methionine by substituting a sulfur atom with a carbon atom. In laboratory tests using rat brain cells, the modified version did not produce free radicals or kill brain cells, according to the researcher.

To determine whether the laboratory results could translate to living organisms, Butterfield joined forces with Christopher D. Link, Ph.D., a researcher at the University of Colorado's Institute for Behavioral Genetics in Boulder, Colo. The researchers obtained genetically modified worms that were able to produce either normal human beta-amyloid or methionine-substituted amyloid. The worms making normal beta-amyloid produced free radicals, which caused damage to the worm muscle proteins. The worms making methionine-substituted amyloid did not produce free radicals; hence, there was no damage to the muscle proteins.

Recent studies have demonstrated that higher than normal doses of vitamin E may slow the advance of Alzheimer's in some people with late stages of the disease. The current study provides a possible explanation for this link. Vitamin E, an antioxidant, appears to work by destroying free radicals (oxidants) produced by amyloid, says Butterfield.

"Our research provides an important insight into this mechanism and offers an appropriate rationale for antioxidant intervention in Alzheimer's," says Butterfield.

The finding provides yet another clue in unraveling the complex mystery of Alzheimer's. A growing number of factors have been associated with the disease, including stress, prior head injury, viruses, genes and abnormal concentrations of metal ions in the brain, including aluminum, zinc, copper, iron, mercury and lead.

In addition to drugs, vaccines and gene therapy are promising targets for treating the disease, which affects an estimated 4 million people in the United States. Unless better treatments are found, that figure is predicted to rise to 14 million later this century, says Butterfield, who calls Alzheimer's a potential public health crisis.

More than 8,000 research papers will be presented during this year's International Chemical Congress, which is sponsored jointly by the American Chemical Society, the Chemical Society of Japan, the Canadian Society of Chemistry, the Royal Australian Chemical Institute and the New Zealand Institute of Chemistry.
-end-
The paper on this research, MEDI 572, will be presented at 11:05 a.m., Monday, Dec. 18, at the Hilton Hawaiian Village, South Pacific Ballroom III, Mid-Pacific Conference Center, during the symposium, "Alzheimer's Disease: Receptors and Small Molecule Therapies."

Allan Butterfield is a professor in the department of chemistry at the University of Kentucky in Lexington, Ky.

Christopher D. Link is a research scientist in the Institute for Behavioral Genetics at the University of Colorado in Boulder, Colo.

The National Institute on Aging and the state of Kentucky supported the study.

American Chemical Society

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.